David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.04% |
| 2 | Healthcare | 13.44% |
| 3 | Consumer Discretionary | 13.38% |
| 4 | Financials | 7.19% |
| 5 | Industrials | 6.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2951
PUT
CACI
CACI
$13.5B
| $510K | ﹤0.01% |
2,800
| – | – |
|
2952
PUT
Williams-Sonoma
WSM
$27.6B
| $506K | ﹤0.01% |
18,000
| – | – |
|
|
DS
2953
DELISTED
Drive Shack Inc.
DS
| $504K | ﹤0.01% |
112,191
+23,895
| +27% | +$108K |
|
|
MNDT
2954
PUT
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $504K | ﹤0.01% |
30,000
-30,000
| -50% | -$505K |
|
|
MDR
2955
DELISTED
McDermott International
MDR
| $504K | ﹤0.01% |
67,700
+41,700
| +160% | +$344K |
|
2956
CALL
Zoetis
ZTS
$31.9B
| $503K | ﹤0.01% |
5,000
| – | – |
|
2957
ANI Pharmaceuticals
ANIP
$1.74B
| $501K | ﹤0.01% |
7,102
+1,308
| +23% | +$77K |
|
2958
CALL
Matador Resources
MTDR
$6.87B
| $501K | ﹤0.01% |
+25,900
| New | +$483K |
|
2959
PUT
Royal Gold
RGLD
$22.7B
| $500K | ﹤0.01% |
5,500
-42,600
| -89% | -$3.72M |
|
2960
Chefs' Warehouse
CHEF
$4.56B
| $499K | ﹤0.01% |
+16,056
| New | +$526K |
|
2961
Lithia Motors
LAD
$8.18B
| $499K | ﹤0.01% |
5,383
+2,469
| +85% | +$215K |
|
2962
Kaiser Aluminum
KALU
$2.51B
| $498K | ﹤0.01% |
4,752
-11,436
| -71% | -$1.16M |
|
2963
CALL
Markel Group
MKL
$22.4B
| $498K | ﹤0.01% |
500
-500
| -50% | -$508K |
|
2964
TechTarget
TTGT
$281M
| $498K | ﹤0.01% |
30,618
-1,100
| -3% | -$16.5K |
|
2965
AppFolio
APPF
$7.9B
| $496K | ﹤0.01% |
6,250
-5,013
| -45% | -$335K |
|
|
RRD
2966
DELISTED
RR Donnelley & Sons Co.
RRD
| $493K | ﹤0.01% |
104,500
-153,497
| -59% | -$791K |
|
|
STI
2967
CALL
DELISTED
SunTrust Banks, Inc.
STI
| $492K | ﹤0.01% |
8,300
-5,000
| -38% | -$306K |
|
|
CRZO
2968
CALL
DELISTED
Carrizo Oil & Gas Inc
CRZO
| $490K | ﹤0.01% |
39,300
-36,300
| -48% | -$432K |
|
2969
American Vanguard Corp
AVD
$66.1M
| $489K | ﹤0.01% |
28,376
-8,695
| -23% | -$153K |
|
2970
Ryman Hospitality Properties
RHP
$9.17B
| $484K | ﹤0.01% |
5,883
-65,619
| -92% | -$5.24M |
|
|
CLDR
2971
DELISTED
Cloudera, Inc.
CLDR
| $482K | ﹤0.01% |
+44,021
| New | +$566K |
|
2972
Tucows
TCX
$101M
| $481K | ﹤0.01% |
+5,925
| New | +$431K |
|
|
SUP
2973
DELISTED
Superior Industries International
SUP
| $480K | ﹤0.01% |
100,826
-89,772
| -47% | -$480K |
|
|
NSTG
2974
CALL
DELISTED
NanoString Technologies, Inc.
NSTG
| $479K | ﹤0.01% |
+20,000
| New | +$460K |
|
|
USCR
2975
DELISTED
U S Concrete, Inc.
USCR
| $478K | ﹤0.01% |
11,542
-10,579
| -48% | -$406K |
|
Similar funds
David Shaw's Q1 2019 Portfolio in Review
As of Q1 2019, David Shaw held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
David Shaw withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Lyft worth $159M.
- David Shaw's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- David Shaw added most to Pfizer in Q1 2019, an estimated $436M increase.
- David Shaw's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- David Shaw fully exited Shire pic in Q1 2019, selling an estimated $276M.
- David Shaw's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- David Shaw opened 447 new positions and closed 617 in Q1 2019.
- David Shaw's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.